Harvey Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWX
Time Warner Inc
TWX
|
+$6.24M |
| 2 |
AT&T
T
|
+$5.71M |
| 3 |
Zions Bancorporation
ZION
|
+$3.93M |
| 4 |
Skyworks Solutions
SWKS
|
+$3.71M |
| 5 |
Verizon
VZ
|
+$3.02M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nektar Therapeutics
NKTR
|
+$5.04M |
| 2 |
Broadcom
AVGO
|
+$4.5M |
| 3 |
Hexcel
HXL
|
+$1.85M |
| 4 |
SKX
Skechers
SKX
|
+$1.58M |
| 5 |
Akamai
AKAM
|
+$1.21M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 24.1% |
| 2 | Technology | 14.3% |
| 3 | Healthcare | 12.83% |
| 4 | Financials | 12.08% |
| 5 | Consumer Discretionary | 12% |
Similar funds
Harvey Capital Management's Q4 2017 Portfolio in Review
As of Q4 2017, Harvey Capital Management held 85 positions worth $276M, up 11% from $248M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Harvey Capital Management deployed $13.6M of net new capital in Q4 2017, opening 8 new positions and adding to 24 existing holdings. Its largest new stake was Zions Bancorporation: 82,025 shares worth $4.17M.
By sector, the portfolio is most concentrated in Communication Services at 24% of assets, up from 19% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Nektar Therapeutics, an estimated $5.04M trimmed.
- Harvey Capital Management's largest Q4 2017 buy was Zions Bancorporation: 82,025 shares worth $4.17M.
- Harvey Capital Management added most to Time Warner Inc in Q4 2017, an estimated $6.24M increase.
- Harvey Capital Management's biggest Q4 2017 reduction was Nektar Therapeutics, cutting an estimated $5.04M.
- Harvey Capital Management fully exited Walgreens Boots Alliance in Q4 2017, selling an estimated $772K.
- Harvey Capital Management's ten largest holdings make up 39% of its $276M portfolio in Q4 2017.
- Harvey Capital Management opened 8 new positions and closed 3 in Q4 2017.
- Harvey Capital Management's portfolio value rose 11% quarter-over-quarter to $276M.
Based on Harvey Capital Management's 13F filing for Q4 2017, filed 2 Feb 2018.